Aion Therapeutics’ (AION.C) joint testing with Apollon Formularies has revealed that their combined formulations are effective in killer HER-positive (HER2+) breast cancer cells. “Our recent medicinal mushroom formulation testing…
Biotech
Novamind (NM.C) announced that they have opened a new Novamind Client Care Center to manage the “overwhelming demand for its treatments”. The new client care center is located in…
They seem to have been born that way. They are naturally incapable of grasping and developing a manner of living which demands rigorous honesty. Today Alcoholics Anonymous (AA) is…
Cybin (CYBN.NE) announced that the Institutional Review Board (IRB) has granted them approval to begin the study of its sublingual psilocybin formulation, CYB001, in a Phase II clinical trial…
Survivors of childhood trauma Everyone’s therapy journey is different. Some people can move past what they are dealing with purely through talk therapy. By understanding on a logical level…
Revive Therapeutics (RVV.C), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare diseases, announced today that it has entered into…
Delic Holdings (DELC.C) announced that their acquisition target, Complex Biotech Discovery Venture (CBDV), has closed their previously-announced non-brokered private placement. The private placement consists of 11,441,189 CBDV Subscription Receipts…
Esketamine Braxia Scientific (BRAX.C), formerly known as Champignon Brands had a rough 2020. It was a down year for many of us, but Champignon really found itself in trouble…
Serotonin over psychedelics Bright Minds Biosciences (DRUG.C) isn’t banking on recreational psychedelics being relevant any time soon, they aren’t selling mushroom powder, and don’t own any ketamine clinics. Rather,…
PsyBio Therapeutics (PSYB.V) announced they have filed a new provisional patent application with the US Patent and Trademark Office. The patent, titled Optimized Methods for the Production of Psilocybin…